Long Noncoding RNA RROL Provides Chromatin Scaffold for MYC-WDR82 Interaction to Impact Lipid Metabolism and Tumor Cell Growth in Multiple Myeloma
Morelli, E.; Fulciniti, M.; Samur, M. K.; Ribeiro, C. F.; Wert-Lamas, L.; Henninger, J. E.; Gulla, A.; Aktas-Samur, A.; Todoerti, K.; Talluri, S.; Park, W. D.; Federico, C.; Scionti, F.; Amodio, N.; Bianchi, G.; Johnstone, M.; Liu, N.; Gramegna, D.; Russo, N. A.; Lin, C.; Tai, Y.-T.; Neri, A.; Chauhan, D.; Hideshima, T.; Shammas, M.; Tassone, P.; Gryaznov, S.; Young, R.; Anderson, K. C.; Novina, C.; Loda, M.; Munshi, N. C.
Show abstract
Long noncoding RNAs (lncRNA) can drive the tumorigenesis and be susceptible to therapeutic intervention. To define the landscape of therapeutically actionable lncRNA dependencies in multiple myeloma (MM), we coupled our extensive lncRNA transcriptomic profile with lncRNA targeted CRISPR interference viability screen and identified RNA Regulator of Lipogenesis (RROL) as a leading lncRNA dependency in MM. RROL shares its origin with the microRNA locus MIR17HG, however supports the proliferation and survival of MM cells in a microRNA- and DROSHA- independent manner. We found that RROL provides a chromatin scaffold for the functional interaction between c-MYC and WDR82 to promote the regulation of the lipogenic pathways via the transcriptional control of the rate-limiting enzyme ACC1 in MM cells. Inhibition of RROL with clinically applicable antisense molecules disrupts its transcriptional and functional activities causing potent anti-tumor effects both in vitro and in vivo in two pre-clinical animal models. This study establishes lncRNA RROL as a therapeutically actionable dependency with a unique mechanism of action in support of myeloma cell growth.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Aberrant non-canonical NF-kappaB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma 94%
- The pan-cancer lncRNA PLANE regulates an alternative splicing program to promote cancer pathogenesis 93%
- MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas 93%
Similar papers in this journal
- G9a Promotes Breast Cancer Recurrence Through Repression of a Pro-inflammatory Program 94%
- Guiding ATR and PARP inhibitor combinations with chemogenomic screens 93%
- Recruitment of BAG2 to DNAJ-PKAc scaffolds promotes cell survival and resistance to drug-induced apoptosis in fibrolamellar carcinoma 93%
Similar papers in this journal
Similar papers in this journal
- DiPRO1 dependent transcriptional and epigenetic regulation distinctly controls the fate of muscle and mesenchymal cancer cells. 92%
- Targeting Pre-existing Club-Like Cells in Prostate Cancer Potentiates Androgen Deprivation Therapy 92%
- Exploiting a metabolic vulnerability in brain tumour stem cells using a brain-penetrant drug with safe profile 92%
Similar papers in this journal
- Activation of the Integrated Stress Response in drug-tolerant melanoma cells confers vulnerability to mitoribosome-targeting antibiotics. 92%
- WDR82-binding long non-coding RNA lncEry controls mouse erythroid differentiation and maturation 91%
- Combinatory therapy targeting mitochondrial oxidative phosphorylation improves efficacy of IDH mutant inhibitors in acute myeloid leukemia 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.